â– PHYSIOLOGICAL CORE: Bile acids are amphipathic molecules containing both a hydrophilic and hydrophobic domain, which allows them to assemble into mixed micelles.
â– DETAILED emulsificationS:
1. Critical Micelle Concentration (CMC): Once bile acid concentration exceeds the CMC, molecules spontaneously assemble into spherical aggregates called micelles.
2. Hydrophobic Core: The hydrophobic cores face inward, sequestering lipid digest products (fatty acids, monoglycerides, cholesterol, and fat-soluble vitamins).
3. Hydrophilic Shell: The hydrophilic shells face outward, keeping the lipids dissolved in the aqueous chyme of the intestinal lumen.
4. Duodenal Transit: Micelles transport the insoluble lipids through the aqueous layer to the enterocyte brush border, where they are absorbed passively.
â– PHARMACOKINETIC & PHARMACODYNAMIC ATTRIBUTES:
Absorption and steady-state kinetics display high variability based on plasma protein binding levels, tissue volume of distribution (Vd), and hepatic CYP450 microsomal enzymatic clearance indices.
â– PHARMACODYNAMIC TARGET ENGAGEMENT:
Receptor binding dynamics dictate the overall speed, duration, and magnitude of physiological responses to therapeutic agents.
[HY-BOARD-1372]
🌟 Dynamic Clinical Key:
Conditions that impair micelle formation (e.g., severe liver disease limiting bile acid synthesis, or biliary tree obstruction) cause fat malabsorption. This leads to steatorrhea (fatty stools) and deficiencies of fat-soluble vitamins, particularly Vitamin K deficiency (which can prolong the prothrombin time). Closely monitor serum plasma concentrations if drugs display a narrow therapeutic window to mitigate toxic peaks. Watch closely for ligand-receptor saturation effects and subsequent tolerance or resistance.